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Interest in ambitious new research to improve
children’s health has been spurred by past suc-
cesses in identifying adverse effects of environ-
mental exposures on children, coupled with
growing awareness of the mechanisms under-
lying children’s susceptibility and the current
exposures and risks they undergo. During cer-
tain periods of development, or “critical win-
dows,” exposure to a toxic agent can have
much more severe consequences than would a
similar exposure in adulthood (Selevan et al.
2000). In addition, infants have immature
mechanisms for metabolism (Balisteri 2000)
and excretion (Kleinman 1982) of toxicants.
Newborns also have a higher surface area and
respiratory minute ventilation per unit body
weight; therefore, a given external exposure
can result in larger intake of an agent com-
pared with that of adults (Snodgrass 1992).
Furthermore, children’s behavior can result in
a higher exposure and internal dose given the
same environment as that of adults (Freeman
et al. 2001). Recently, the effect of early-life
events on subsequent chronic disease in
adults—the “fetal origins hypothesis”—has
gained acceptance (Lucas et al. 1999).
Advances in analytical chemistry are making it
increasingly clear that children are exposed to
a host of environmental agents (CDC 2001).
Furthermore, characterization of the human
genome could lead to medical breakthroughs
given appropriate research (Collins and
McKusick 2001). The increasing scientific
momentum to study children’s health is
reﬂected by the recent inception of the Danish
National Birth Cohort (Olsen et al. 2001) and
the Norwegian Mother and Child Cohort
Study (Magnus 2001), both projected to
include more than 100,000 pregnant women
and their children.
Previous major studies of the consequences
of early-life exposures provide some insights
into the importance and potential of such pro-
jects. For example, data from the Collaborative
Perinatal Project (CPP; Nelson and Ellenberg
1976), a study involving a cohort of more than
50,000 pregnant women and their children
that was conducted by the U.S. National
Institutes of Health and scientists at 12 univer-
sities beginning in 1959 (Broman 1984), made
a major contribution to stopping the frequent
but unnecessary treatment of febrile seizures
and to an improved understanding of the etiol-
ogy of cerebral palsy (Nelson and Ellenberg
1986) and sudden infant death syndrome
(Naeye et al. 1976). Furthermore, some of the
earliest data on the risk to children from expo-
sure to lead (de la Burde and Choate 1975) and
fetal exposure to alcohol (Jones et al. 1974)
came from the CPP. Although the overall con-
tribution of the CPP (reviewed in CPP 2001) is
difﬁcult to evaluate and characterize, the CPP
and other such studies attest to the value of
large cohort studies of children for addressing
both speciﬁc and general health questions.
In this article, we describe a concept for a
large new U.S. cohort study of children.
Because the full study design and proposal
are still under development, we present here
those aspects for which there is already agree-
ment, the anticipated scope and capabilities
of the study, and a few speciﬁc potential core
hypotheses. As a more detailed example of
the many applications, we briefly discuss
how the proposed study might support
research on the potentially adverse effects of
chemical contaminants in breast milk.
Development and History of
the National Children’s Study
In 1997 the President’s Task Force on
Environmental Health Risks and Safety Risks
to Children (President’s Task Force 2000) was
charged with developing strategies to reduce or
eliminate adverse effects on children caused by
environmental exposures. The task force recog-
nized that to develop such strategies, a much
clearer understanding of risk factors was essen-
tial. Consequently, the task force proposed a
longitudinal cohort study of the effects of envi-
ronmental exposure (broadly deﬁned) on the
health and development of children.
In January 2000, the Developmental
Disorders Work Group of the task force
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Children’s Health Commentaryconvened an expert panel to provide advice
regarding the proposal (President’s Task Force
2000). The panel considered the experiences of
a number of experts from past or ongoing
major longitudinal studies and discussed the
feasibility of embarking on such a large
national study. Overviews were presented of
the CPP (Broman 1984), the Child Health and
Development Studies (van den Berg et al.
1988), the Danish National Birth Cohort
study (Olsen et al. 2001), the Bogalusa Heart
Study (Berenson 2001), the Avon Longitudinal
Study of Pregnancy and Childhood (Golding
et al. 2001), and the Nurses’ Health Study
(Colditz et al. 1997). Besides a strong endorse-
ment of the proposed new study, the panel rec-
ommended that a) speciﬁc hypotheses should
be developed and applied; b) families should
be included along with index children; c) plan-
ning must address ethical issues of collection,
storage, and distribution of information,
including biologic specimens, genetic material,
and environmental samples; d) collaboration
among many federal agencies is essential;
e) modern information technology and bioana-
lytic and environmental monitoring tech-
niques should be incorporated; and f) new
funds would have to be appropriated from
Congress to carry out the study. The ﬁnal mes-
sage to the work group was to think boldly in
planning for such a study.
Subsequently, the Children’s Health Act of
2000 (§1004) authorized the National Institute
of Child Health and Human Development
(NICHD) “to conduct a national longitudinal
study of environmental inﬂuences (including
physical, chemical, biological, and psychoso-
cial) on children’s health and development.” It
instructed the director of the NICHD to 
establish a consortium of representatives from
appropriate Federal agencies (including the
Centers for Disease Control and Prevention, the
Environmental Protection Agency) to: 1) plan,
develop, and implement a prospective cohort study
from birth to adulthood to evaluate the effects of
both chronic and intermittent exposures on child
health and human development; and 2) investigate
basic mechanisms of developmental disorders and
environmental factors, both risk and protective,
that inﬂuence health and developmental processes.
This mandate was passed with strong bipartisan
support, but without supporting appropriations.
To lead the planning and implementation
of the study, staff and funds have been allocated
by the NICHD, the National Institute for
Environmental Health Sciences (NIEHS), and
the Centers for Disease Control and Prevention
(CDC), all in the Department of Health and
Human Services, and by the Ofﬁce of Research
and Development of the U.S. Environmental
Protection Agency (U.S. EPA). Investigators
from each of these four lead entities serve on an
Interagency Coordinating Committee (ICC)
that has further developed the conceptual
framework for the study, as well as an adminis-
trative structure and process for planning the
study. The ICC has named the project the
National Children’s Study (NCS).
The Conceptual Framework for
the NCS
In addition to the outline of the study given
in the Children’s Health Act (2000), the ICC
has proposed that the study should evaluate
low-level but relatively frequent exposures as
opposed to rare or episodic events, that full
advantage be taken of recent advances in
genetics and measurement of gene expression,
and that the study serve as a national resource
that accommodates future investigations not
yet conceived. Furthermore, speciﬁc high-risk
populations, such as the economically disad-
vantaged, agricultural worker families, and
others, will be included in special samples to
provide sufﬁcient power to examine selected
effects in these subgroups.
As a first step in defining the scope and
design of the study, priority outcomes for
examination in the NCS will be selected.
Criteria for selecting the priority outcomes will
include the following: a) a frequency high
enough that effects of exposures can be
detected with reasonable statistical power,
b) sufﬁcient public health signiﬁcance to merit
the study (morbidity and disability, mortality,
cost, or other concerns, e.g., rising incidence),
and c) feasibility of reliable measurement. The
preliminary list of priority topics includes unde-
sirable outcomes of pregnancy, speciﬁcally birth
defects and preterm birth; altered neurobehav-
ioral development, developmental disabilities,
and psychiatric outcomes; injury; asthma; and
obesity and altered physical development.
For each priority topic, core hypotheses
will be selected, and these will provide speci-
ficity in the scope and design of the study.
Criteria for selecting core hypotheses include
the following: a) the distribution of expo-
sure should be such that effects, if any, can
be detected with reasonable statistical power;
b) the exposure can be reliably measured;
c)a   plausible theoretical rationale exists for
the hypothesis(es); and d) a large, prospec-
tive study is necessary to test the hypothesis.
Examples of specific, potential core
hypotheses for which additional data are clearly
needed are as follows: a) Among women with-
out diabetes before pregnancy, impaired
glucose metabolism during pregnancy is pro-
portional to risk of major congenital malforma-
tions of the heart, central nervous system,
musculoskeletal system, and all birth defects
combined (Aberg et al. 2001). b) Chronic low-
level pesticide exposure early in life has adverse
effects on neurodevelopment and cognition
(Eskenazi et al. 1999). c) Infection during preg-
nancy that is not associated with fetal or neo-
natal meningitis or encephalitis can affect
neurodevelopment and risk of psychiatric
illness in offspring (Nelson and Willoughby
2002). d) Exposure to indoor and outdoor air
pollution and bioaerosols (including allergens,
endotoxin, and mold) is associated with
increased risk of asthma (Martinez 2002).
e) Impaired glucose metabolism during preg-
nancy increases the rate of insulin resistance in
adolescent offspring (Fagot-Campagna et al.
2000; Seidman et al. 1998).
Although the NCS will be national in
scope, various sampling strategies are under
consideration. Ideally, results would be gener-
ally representative of the U.S. population or
some large portion thereof, although statistical
representation is unlikely. The use of geograph-
ically distributed study centers for recruitment,
measurement, and follow-up is likely.
A total sample resulting in approximately
100,000 children, after accounting for attri-
tion, has been proposed with follow-up to 21
years of age, although the final decision
regarding study size will depend on the spe-
ciﬁc core hypotheses. Inclusion of other family
members may be desirable, especially to facili-
tate studies of gene–environment interaction,
fertility, and social environment.
For dichotomous outcomes, a study of
the magnitude proposed for the NCS is best
justified by hypotheses regarding conditions
with a risk (by age 21) on the order of 2 per
1,000 (0.2%). Figure 1 shows the smallest
detectable relative risk, according to exposure
prevalence, with a power of 80% and a two-
sided α of 0.05, given cohorts numbering
100,000 and 200,000 (CDC 2001b).
Cerebral palsy, type 1 diabetes, autism
spectrum disorder, and schizophrenia all
occur in about 0.2% of the population by age
21 years (Table 1). Hypospadias among
males occurs with a frequency of about 0.4%,
but in a population of males and females the
effective frequency is about 0.2%. The risk of
severe mental retardation is about 0.4%.
Neural tube defects (spina bifida, anen-
cephaly) and acute lymphocytic leukemia (the
most frequent childhood cancer) have risks
closer to 0.05%, and only relative risks greater
than 2 could be detected with reasonable power
in a study of 100,000 (Figure 2). For these con-
ditions, doubling the sample size would still not
provide much statistical power unless the expo-
sure was frequent. Of course, risk of any child-
hood cancer is greater, but the wisdom of
grouping all cancers is debatable. Combining
neural tube defects, however, is often done, but
the risk would still be near 0.1%.
The question of how best to group out-
comes arises also in the context of many other
conditions potentially of interest (e.g.,
injuries). Although traumatic brain injury is a
seemingly homogeneous entity, for etiologic
research, grouping injuries that occurred
among teenage drivers in automobile accidents
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not in cars makes little sense; thus, appropri-
ately grouped outcomes may be more rare than
they appear in Table 1.
Studies of outcomes such as asthma, atten-
tion deﬁcit–hyperactivity disorder, and child-
hood obesity, which are relatively frequent, do
not require huge samples in prospective studies.
For these important conditions, however, the
NCS could offer the opportunity to study risk
factors within various (e.g., genetic or ethnic)
subgroups, risk factors for different levels of dis-
ease severity, or health disparities.
A follow-up of the cohort beyond 21 years
of age would allow sufﬁcient power to study
many frequent chronic diseases of adulthood,
such as speciﬁc cancers, heart disease, type 2
diabetes, and stroke, if subject retention
remains high. Before adulthood, however, envi-
ronmental inﬂuences on preclinical markers of
adult diseases could be examined.
In general, continuous outcomes such as
cognitive ability require smaller samples for
sufficient power (Bhandari et al. 2002),
although if the exposure under study is very
low, large samples could still be required to
detect subtle effects.
Enrollment of parents planning pregnancy
is appealing for several reasons but could pose
daunting logistical challenges and yield a
study population not representative of the
general population. Women will be enrolled
as early as possible in pregnancy, and fertility
and exposures preconceptually or during criti-
cal windows very early in pregnancy may be
examined either in later pregnancies among
enrolled mothers or in a sample of couples
recruited before pregnancy.
Final aspects of the design will depend on
the core hypotheses, ﬁnancial resources, utility
for future investigations, and ethical considera-
tions—including subject burden. Plans to
date, however, anticipate collection of a wide
range of environmental and biologic samples
from the parents, the children, and their envi-
ronment, as well as assessment of pregnancy
outcome, birth defects, neurodevelopment,
cognition, and behavior; respiratory, immune,
and endocrine function; and reproductive
development, body size, cardiovascular risks,
and experience with infectious diseases. In
addition, the social environment, home envi-
ronment, schools, and access to health services
will be evaluated to determine, to the extent
possible, the complete environment of the chil-
dren. In some instances, measurement meth-
ods will need to be developed and tested. For
example, inexpensive, ﬁeld-ready methods to
assess environmental chemicals and biologic
markers of exposure in human blood and urine
will require development and reﬁnement. The
most appropriate samples for present and
future genomic assessments and analysis will
need to be developed and tested. Approaches
to community involvement will also need to
be developed. For example, subject acceptance
of collecting and retaining these data will need
to be examined and pilot tested. Therefore, a
series of focus groups, feasibility studies, and
pilot tests will be undertaken to derive the
optimum assessment batteries at respective
ages. Internet technology and other state-of-
the-art information technology will be used for
data collection where appropriate and for data
transfer among the data collection centers and
the data management center (Marshall and
Haley 2000).
Administrative Structure
Figure 3 shows the present organizational
chart for the NCS, for the planning phase. As
noted above, a committee of scientists (the
ICC) is responsible for the planning and
implementation of the NCS. The ICC con-
sists of appointed representatives from each of
the lead federal organizations (NICHD,
CDC, NIEHS, and U.S. EPA). As specified
in the Children’s Health Act of 2000, the
Director of the NICHD is accountable for the
study. A program ofﬁce for the NCS has been
established at NICHD.
A unique aspect of this structure is the
input of both federal and nonfederal scientists
for planning the study via the activities of the
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Figure 1. Power calculations with a disease prevalence of 0.2%: smallest
detectable relative risk, according to exposure prevalence, for two cohort sizes.
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Table 1. Approximate risk by age 21 of selected conditions of childhood.
Condition Risk (%) Reference
Spina biﬁda 0.04 Feuchtbaum et al. (1999)
Anencephaly 0.05 Feuchtbaum et al. (1999)
Acute lymphocytic leukemia 0.06 National Cancer Institute (2002)
Cerebral palsy 0.2 Kuban and Leviton (1994)
Musculoskeletal birth defects 0.2a Becerra et al. (1990), Hoffman and Kaplan (2002)
Type 1 diabetes 0.2b Onkamo et al. (1999)
Autism spectrum disorder (DSM IV) 0.3 Yeargin-Allsopp et al. (2003)
Central nervous system birth defects 0.3a Becerra et al. (1990), Hoffman and Kaplan (2002)
Schizophrenia 0.3 Bresnahan et al. (2000)
Hypospadias (males) 0.4 Paulozzi (1999), Choi et al. (2001)
Mental retardation (severe) 0.4 Roeleveld et al. (1997)
Congenital heart defects 0.6 Hoffman and Kaplan (2002)
Asthma 6c Mannino et al. (2002)
Traumatic brain injury 10d Guerrero et al. (2000)
Attention deﬁcit–hyperactivity disorder 10 Rowland et al. (2002)
aFrequency based on the ratio of cases in relation to those of congenital heart defects, and data on the frequency of
congenital heart defects. bTo age 14 years; based on the average of three U.S. studies reported in Onkamo et al. (1999).
cPrevalence in past 12 months among children 5–14 years old. dTo age 14 years.
Figure 2. Power calculations with a disease prevalence of 0.05%: smallest
detectable relative risk, according to exposure prevalence, for two cohort sizes.
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0.02 0.05 0.1 0.2 0.3 0.4working groups, which are under the auspices
of the NCS Advisory Committee (NCSAC).
[The NCSAC was chartered under the Federal
Advisory Committee Act 1982.] More than 20
working groups composed of both federal and
nonfederal scientists and representatives of key
nongovernmental organizations focus on spe-
ciﬁc scientiﬁc aspects of planning and conduct-
ing the study. Some working groups will
attend to overarching and integrative themes,
whereas others will focus on speciﬁc hypothe-
sis-related subject matter areas (Appendix).
Considerable interaction and communication
among these working groups will be necessary.
A list of the working group members can be
viewed at the NCS web site (NCS 2002).
These working groups include members from
more than two dozen federal agencies, three
dozen universities, and many professional and
other organizations. At the time of this
writing, more than 250 scientists were working
group members. The ﬁndings of these working
groups will be integrated and reviewed by the
NCSAC, which will make recommendations
to the ICC. The NCS program office will
administer the necessary pilot studies and feasi-
bility studies, draft the full protocol, and
conduct detailed planning.
All agencies, organizations, scientists, and
individuals interested in participating in the
study or staying apprised of progress are
included in the overall study assembly that
meets periodically to receive updates on study
planning and progress. The study assembly
provides a forum to discuss issues related to
the study.
Assessment of Potential
Effects of Chemical
Contaminants of Breast Milk
Facilitating studies of the potentially adverse
effects of environmental contaminants is one
goal among many for the NCS. In this section,
as an example, we discuss use of the NCS to
examine the health effects of chemical contam-
inants in breast milk. Among the more notable
persistent organic pollutants in breast milk are
the DDT (dichlorodiphenyltrichloroethane)
metabolite DDE (dichlorodiphenyldichloro-
ethylene), polychlorinated biphenyls (PCBs),
polybrominated diphenyl ethers (PBDEs), and
tetrachlorodibenzo-p-dioxin (TCDD) (Hooper
and McDonald 2000; Rogan 1996). Because
breast milk is 3.7% fat by weight, lipophilic
xenobiotics partition into it. Thus, breast-
feeding results in a greater maternal–child
transfer of persistent organic pollutants than
occurs in utero. Whether early-life exposure to
any of these persistent organic pollutants has
adverse effects within the range of current
background exposure is unclear (Table 2).
The evidence regarding potential adverse
effects cited in Table 2 refers mostly to studies
in populations with slightly higher exposure
levels than now found in the United States.
For some pollutants that are present at
extremely low levels but are also potent, assess-
ing exposure in breast milk is advantageous
because levels can be detected in smaller vol-
umes than is possible using other types of
specimens such as blood.
Although levels of most persistent organic
pollutants in humans are decreasing (Schade
and Heinzow 1998; Smith 1999), those of
PBDEs are increasing (Hooper and McDonald
2000), and new data on current levels are
needed. The possibility exists that there are
other toxic pollutants in breast milk that have
not yet been discovered.
In addition to persistent organic pollu-
tants, breast milk contains the persistent toxic
substances lead and mercury. The level at
which no adverse effect occurs for either of
these compounds is still a matter of contro-
versy (Lanphear et al. 2000; NRC 2000), and
additional studies of the contribution of breast
milk exposure to adverse effects may be called
for in the future. Furthermore, other exoge-
nous chemicals such as alcohol, nicotine, and
caffeine can be found in breast milk (Golding
1997), and the potential adverse effects of
exposure to these compounds via this route is
still under investigation. Comprehensive lists
of breast milk contaminants can be found
elsewhere (Golding 1997; Jensen 1983; Pohl
and Tylenda 2000; Rogan 1996).
Although studies of chemical contami-
nants in breast milk in relation to a variety of
health outcomes have been done previously
(Vreugdenhil et al. 2002; Walkowiak et al.
2001), such studies have been hobbled by
their modest sample size. The NCS would
greatly enhance the ability to distinguish
among effects of exposures that so often are
found in concert in breast milk, such as PCBs
and dioxins. Furthermore, the large sample
size would facilitate evaluation of risk associ-
ated with the mixture of exposures that
humans are subject to, an intractable problem
in smaller studies. Thus, collection of breast
milk samples in the NCS would render the
study extremely useful for providing guidance
of health care and public policy related to
breast-feeding of infants.
Although breast milk may contain poten-
tially toxic chemicals, the World Health
Organization and the American Academy of
Pediatrics have weighed the beneﬁts of breast-
feeding against any possible risks incurred and
have consistently supported breast-feeding as
the method of choice for infants (Brouwer et
al. 1998; Committee on Environmental
Health 1999). The data collected in the NCS
should be helpful in supporting or modifying
this recommendation.
Conclusion
Our nation is in the unique position of being
able to give children’s environmental health
the priority it deserves. A long-range, large-
scale child cohort is needed to take full advan-
tage of scientiﬁc and technologic advances and
to enable greater prevention of humankind’s
current and future plights (National Science
and Technology Council 1997). The effort to
launch a large new cohort study of U.S. chil-
dren has considerable momentum. To keep
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Figure 3. NCS organizational chart.
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Table 2. Selected pollutants and other toxic chem-
icals in breast milk, and corresponding potential
adverse effects in offspring.
Agent Potential adverse effect
DDE Decreased stature (Karmaus et al.
2001, 2002)
PCBs Altered thyroid economy (Osius et al. 1999),
Adverse effect on neurodevelopment
(Walkowiak et al. 2001)
PBDEs Altered thyroid economy (Zhou et al. 2001)
TCDD Hydronephrosis (Couture-Haws et al. 1991)
Mercury Hypertension (Sorensen et al. 1999)
Alcohol Adverse effects on motor development
(Little et al. 1989)
Nicotine Increased risk of sudden infant death
syndrome (Klonoff-Cohen et al. 1995)
Appendix. The working groups established for
the NCS.
Asthma
Birth defects
Community outreach and communications
Development and behavior
Early origins of adult health
Ethics
Exposures to chemical agents
Fertility and early pregnancy
Gene–environment interaction
Health disparities and environmental justice
Health services
Information technology
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Immunity, infection, and vaccines
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Nutrition, growth, and pubertal development
Physical exposure
Pregnancy and the infant
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Repository
Social environment
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this ambitious project moving forward,
further development of a compelling ratio-
nale, of the protocol, and of additional pilot
data is critical. Whether the proposed NCS
will be funded will depend on developments
over the next few years.
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